Clinical trial data and emerging strategies: HER2-positive breast cancer. Pernas S, Tolaney SM. Breast Cancer Res Treat 2022 Apr 9. pii: 10.1007/s10549-022-06575.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pernas S, Tolaney SM. Clinical trial data and emerging strategies: HER2-positive breast cancer. Breast Cancer Res Treat 2022 Apr 9. pii: 10.1007/s10549-022-06575.
PMID: 35397080